IRVINE, Calif., Dec. 04, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by measuring somatic copy number … Continue reading “Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study”
Breaking News
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024…
AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business
NEW YORK, Dec. 03, 2024 – PRISM MediaWire – AB International Group Corp. (OTC: ABQQ),…
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery PITTSBURGH, Dec.…
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population …
Halberd Update on WatchDawg® PTSD Treatment
Next Phase Pilot Study Jackson Center, PA, December 2, 2024 – PRISM MediaWire – Halberd…
StemSation International Announces Acquisition of Gorilla Marketing Group, LLC
StemSation International announced today the completion of the acquisition of 100% of the private marketing…
Skyborne Technology, Inc., a UAV Corp Company (UMAV) and Atlantic Industrial Group Inc. (AIG) Announce AI Manufacturing JV for VTOL & Lighter than Air Vehicles
Skyborne’s Costin Airport Grant Infrastructure Project Has Been Completed for The Near Future Build of…
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024
Rani Kohen, Founder, and Steve Schmidt, President of SKYX, to Present at 1:30 PM ET…
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering
HAUPPAUGE, N.Y., Nov. 26, 2024 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW)…
ABQQ Reports FY 2024 Audited Financial Results, Introduces FY 2025 Outlook, Announces to Repurchase $5 Million of Shares by Year-End 2025
FY 2024 REVENUE INCREASED 125% TO A RECORD $3.3 MILLION FY 2024 REACH OPERATIONAL PROFITABILITY…
SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia
SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery…
EzFill Signs Definitive Agreement for the Purchase of Yoshi Mobility’s Fuel Division
Agreement Expands EzFill’s Operations to Four New States Deal Expected to Close December 2 Miami,…
AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market
HAUPPAUGE, N.Y., Nov. 25, 2024 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW)…